
|Podcasts|November 18, 2020
S2E7: Surgeons Panel: The state of gynecologic surgery
Author(s)Lindsey Carr, Editor
In this episode of Pap Talk, Contemporary OB/GYN Deputy Editor Jon I. Einarsson, MD, MPH, PhD, moderates a discussion with Robert K. Zurawin, MD, and Gaby Moawad, MD, on the new and existing surgical technologies and techniques available in ob/gyn.
Advertisement
Zurawin is an adjunct associate professor at the Baylor College of Medicine, Department of ob/gyn.
Moawad is a clinical associate professor of ob/gyn at the George Washington University School of Medicine and Health Sciences, and founder of the Center for Endometriosis and Advanced Pelvic Surgery.
Disclosures
Zurawin is the principal medical advisor for Memic Innovative Surgery Ltd., the company that created the Hominis surgical system. Moawad is on the Speakers Bureau, Intuitive Surgical.
Advertisement
Related to this article

Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.

Fezolinetant (Veozah) was linked to objective and patient-reported sleep gains in OPTION-VMS, with no new safety signals observed.

HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.

The prospective SOARA study will measure how often a 98%-specific ovarian cancer screening blood test leads to invasive procedures.

Wen Shen, MD, explains how clinicians can counter menopause misinformation from social media and steer patients toward evidence-based resources.

Wen Shen, MD, outlines when to treat perimenopausal symptoms and which history-taking red flags should prompt earlier bone and cardiovascular screening or referral.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves pritelivir tablets to treat lesions from HSV
2
Perimenopause and mental health: Beyond hormonal vs psychological
3
HPV vaccine before pregnancy tied to fewer adverse pregnancy outcomes
4
Ultrasound findings after medication management of early pregnancy loss
5


